IgA Nephropathy is the most common cause of glomerulonephritis worldwide. In 2026, new guidelines recommend simultaneous, aggressive therapy to reduce proteinuria below 0.5 g/day and prevent kidney failure. Learn the latest treatments, prognosis, and patient challenges.
READ MORE